Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Acute Pain After Abdominal Surgery
NCT06530563Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Aug 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in acute pain, sponsored by Xiangya Hospital, Central South University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06530563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06530563.